Benjamin J Eckhardt
Overview
Explore the profile of Benjamin J Eckhardt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kapadia S, Jordan A, Eckhardt B, Perlman D
Clin Infect Dis
. 2023 Aug;
78(5):1235-1239.
PMID: 37633653
Hepatitis C virus (HCV) elimination is an important global public health goal. However, the United States is not on track to meet the World Health Organization's 2030 targets for HCV...
2.
Kapadia S, Aponte-Melendez Y, Rodriguez A, Pai M, Eckhardt B, Marks K, et al.
Harm Reduct J
. 2023 Jul;
20(1):95.
PMID: 37501180
Background: Hepatitis C virus (HCV) treatment can effectively cure HCV among people who inject drugs (PWID). Perspectives of PWID treated in innovative models can reveal program features that address barriers...
3.
Finbraten A, Eckhardt B, Kapadia S, Marks K
Gastroenterol Hepatol (N Y)
. 2023 Mar;
18(11):628-638.
PMID: 36866028
The science for rapid treatment initiation for hepatitis C virus infection is in place. Easy and quick diagnostic tools can provide results within an hour. Necessary assessment before treatment initiation...
4.
Kapadia S, Eckhardt B, Leff J, Fong C, Mateu-Gelabert P, Marks K, et al.
Drug Alcohol Depend Rep
. 2023 Jan;
5.
PMID: 36644226
Background: Co-located hepatitis C treatment at syringe service programs (SSP) is an emerging model of care for people who inject drugs (PWID). Implementation of these models can be informed by...
5.
Mateu-Gelabert P, Sabounchi N, Guarino H, Ciervo C, Joseph K, Eckhardt B, et al.
Front Public Health
. 2022 Aug;
10:835836.
PMID: 35968435
Background: Injection drug use (IDU) is the leading risk factor for hepatitis C virus (HCV) transmission in the U.S. While the general risk factors for HCV transmission are known, there...
6.
Filardo T, Khan M, Krawczyk N, Galitzer H, Karmen-Tuohy S, Coffee M, et al.
PLoS One
. 2020 Nov;
15(11):e0242760.
PMID: 33227019
Background: Despite evidence of socio-demographic disparities in outcomes of COVID-19, little is known about characteristics and clinical outcomes of patients admitted to public hospitals during the COVID-19 outbreak. Objective: To...
7.
Kapadia S, Katzman C, Fong C, Eckhardt B, Guarino H, Mateu-Gelabert P
J Viral Hepat
. 2020 Nov;
28(2):326-333.
PMID: 33141503
Young people who use drugs have a rising hepatitis C (HCV) incidence in the United States, but they may face barriers to testing and treatment adoption due to stigma. We...
8.
Katzman C, Mateu-Gelabert P, Kapadia S, Eckhardt B
Int J Drug Policy
. 2019 Apr;
72:33-39.
PMID: 31010750
Contact tracing has been a key element of the public health response to infectious diseases for decades. These practices have been powerful in slowing the spread of tuberculosis, HIV, and...
9.
Eckhardt B, Scherer M, Winkelstein E, Marks K, Edlin B
Open Forum Infect Dis
. 2018 Apr;
5(4):ofy048.
PMID: 29644246
Hepatitis C virus (HCV) is a significant public health problem that disproportionately afflicts people who inject drugs. We describe outcomes of HCV treatment co-located within a syringe services program (SSP)....
10.
Kupferman T, Coffee M, Eckhardt B
Am J Trop Med Hyg
. 2017 Oct;
97(6):1679-1681.
PMID: 29016310
We report the case of a 46-year-old male abattoir worker who developed myalgias, shortness of breath, and irritability 2 weeks after sustaining a laceration to the hand with a knife...